|Bid||220.67 x 800|
|Ask||220.45 x 900|
|Day's Range||219.19 - 222.42|
|52 Week Range||144.75 - 223.45|
|Beta (3Y Monthly)||1.01|
|PE Ratio (TTM)||23.67|
|Forward Dividend & Yield||2.08 (0.94%)|
|1y Target Est||N/A|
In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby increasing the number of lives saved.
We highlight ETFs which are set to gain from an expanding surgical robotic market on factors like growing demand for automation in healthcare, rising cases of chronic diseases and ageing population.
The robots are coming. Don't be afraid. These machines are changing medicine for the better -- one hip and knee replacement at a time, asserts growth stock expert Jon Markman, editor of Pivotal Point.
So far, the levies and prospect of additional tariffs have not cooled investors’ enthusiasm for the shares of industry members Continue reading...
Stryker, Varian Medical Systems and Becton, Dickinson & Co. could feel pressure after China targeted medical products in another round of tariffs on imports, an analyst said Thursday.
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
President and COO of Stryker Corp (30-Year Financial, Insider Trades) Timothy J Scannell (insider trades) sold 4,666 shares of SYK on 08/16/2019 at an average price of $217.08 a share. Continue reading...